Treatment for Raynaud syndrome isn’t about making it disappear completely. According to Mayo Clinic, the real goals are to reduce how often attacks happen, prevent tissue damage, and treat any underlying condition driving the symptoms. That framing matters, because it shapes how doctors actually approach care.
For most people, treatment starts simple and only escalates if lifestyle changes aren’t enough. Here’s what that progression typically looks like.
Whether you need medication at all usually comes down to how often attacks happen and how much they interfere with daily life. A person who gets cold fingers twice a winter needs a very different plan than someone dealing with painful episodes several times a week.
First Line: Lifestyle Changes, Not Medication
Research in the Cleveland Clinic Journal of Medicine is direct about this: cold avoidance and stress management are first-line therapy for every patient, regardless of whether the case is mild or severe.
In practice, that means dressing in layers, keeping hats and gloves on hand, and using hand warmers in cold weather. Mayo Clinic adds that wearing gloves or heavy socks usually helps manage mild symptoms without needing anything further.
This step is easy to underestimate, but it’s not a placeholder while you wait for medication. Many people with primary Raynaud’s manage the condition this way indefinitely and never need a prescription.
How Diagnosis Shapes the Treatment Plan
Before deciding on treatment, doctors typically confirm what type of Raynaud’s they’re dealing with. Mayo Clinic notes that nailfold capillaroscopy, which uses a microscope to examine the skin at the base of the fingernail, can help distinguish primary from secondary Raynaud’s.
Blood tests play a role too. An antinuclear antibody (ANA) test can flag an autoimmune reaction, which is common in people with connective tissue disease. None of these tests diagnose Raynaud’s on their own, but together they help rule out a secondary cause before treatment decisions are made.
Medication: Calcium Channel Blockers
When lifestyle changes aren’t enough, calcium channel blockers are the standard next step. Mayo Clinic explains that these drugs relax and open the small blood vessels in the hands and feet, which is exactly the mechanism Raynaud’s disrupts.
A Cochrane review of seven randomized trials involving 296 patients found that oral calcium channel blockers, mainly nifedipine, reduced attack frequency by about 1.7 fewer attacks per person per week compared with placebo. That’s a modest but real improvement, and it came with tradeoffs; the same review reported side effects like headaches, flushing, and ankle swelling in some patients.
Doctors typically start at the lowest effective dose and increase it gradually. For people whose symptoms are mostly seasonal, taking the medication only through the colder months is a reasonable approach rather than year-round use.
When Calcium Channel Blockers Aren't Enough
Some patients don’t get adequate relief from calcium channel blockers alone. For these cases, the Cleveland Clinic Journal of Medicine points to phosphodiesterase type 5 (PDE5) inhibitors, the same drug class used for erectile dysfunction, as a next option.
A 2014 meta-analysis of six randomized trials covering 244 patients with secondary Raynaud’s found that PDE5 inhibitors like sildenafil cut the daily frequency of attacks by about 0.5 per day compared with placebo, and also reduced how severe and how long each attack lasted.
Other Options for Persistent Cases
For patients who still struggle after trying both drug classes, the Cleveland Clinic Journal of Medicine describes topical nitrates, applied directly to the base of an affected finger, as a targeted option for digits that are more severely affected than others.
These aren’t first-choice treatments. They’re typically reserved for cases where standard options haven’t worked well enough, and they require close monitoring since combining them with certain other medications isn’t recommended.
The Real Goal Isn’t Zero Attacks
It’s easy to assume successful treatment means never having another episode. That’s not the standard doctors work toward. The Cleveland Clinic Journal of Medicine is clear that the goal should be improving quality of life and preventing tissue damage, not eliminating attacks entirely, since more aggressive treatment can sometimes cause more harm than benefit.
Everyday Habits That Reduce Attack Frequency
Alongside any medication, a handful of daily habits consistently show up in treatment guidance:
- Quit smoking, since nicotine narrows blood vessels on its own
- Warm up hands under warm water at the first sign of an attack
- Limit caffeine, which can amplify vascular reactivity
- Avoid sudden temperature changes, like walking from a warm room into cold air
- Manage stress with a method that actually works for you, whether that’s exercise or something quieter
Adding Daily Circulatory Support
Some people managing Raynaud’s also add a daily supplement aimed at supporting circulation. RaynaFlow from Real Science Nutrition is formulated around nitric oxide pathway support, along with vitamins C, D, K, B6, and B12, to help maintain healthy blood flow as part of a daily routine.
It isn’t a substitute for calcium channel blockers or any prescribed treatment, and it doesn’t treat Raynaud’s directly. It’s best thought of as a daily habit that complements the lifestyle steps above, not a replacement for medical care. Talk to your doctor before adding it, especially if you’re already on medication.
Outlook
For most people, Raynaud syndrome isn’t disabling, and mild cases respond well to lifestyle changes alone. The people who need medication typically do well once they find the right combination, and most never progress to more serious complications like skin ulcers.
The most useful thing you can do is start with the basics, track what triggers your episodes, and bring that information to a doctor if lifestyle changes alone aren’t cutting it. Treatment is rarely one-size-fits-all, and it often takes some adjusting to land on what works for your specific case.